Interferon gamma inhibits adipogenesis in vitro and prevents marrow fat infiltration in oophorectomized mice

Stem Cells

Volumn 30, Issue 5, 2012, Pages 1042-1048

  Vidal, Christopher ^a   Bermeo, Sandra ^a   Li, Wei ^a   Huang, Dao ^b   Kremer, Richard ^b   Duque, Gustavo ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Adipogenesis; Aging; Interferon gamma; Mesenchymal stem cells; Osteoimmunology; Osteoporosis

Indexed keywords

GAMMA INTERFERON; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; ADIPOGENESIS; ADULT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL INFILTRATION; CONTROLLED STUDY; DNA BINDING; DRUG EFFECT; FEMALE; FEMUR; HEMATOPOIESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPID STORAGE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; PROTEIN EXPRESSION;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; ANTIGENS, DIFFERENTIATION; ANTIVIRAL AGENTS; CELL DIFFERENTIATION; FEMALE; HEMATOPOIESIS; HUMANS; INTERFERON-GAMMA; MESENCHYMAL STEM CELLS; MICE; OSTEOBLASTS; OSTEOGENESIS; OVARIECTOMY; PPAR GAMMA;

MUS;

EID: 84860514967     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1063     Document Type: Article

References (38)

1. Raggatt LJ, Partridge NC. Cellular and molecular mechanisms of bone remodeling. J Biol Chem 2010;285:25103-25108.
2. Datta HK, Ng WF, Walker JA et al. The cell biology of bone metabolism. J Clin Pathol 2008;61:577-587. (Pubitemid 351678208)
3. Takayanagi H. Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol 2009;5:667-76.
4. Schett G, David J-P. The multiple faces of autoimmune-mediated bone loss. Nat Rev Endocrinol 2010;6:698-706.
5. Reid I. Relationships between fat and bone. Osteoporos Int 2008;19: 595-606. (Pubitemid 351642171)
6. Barbour KE, Zmuda JM, Boudreau R et al. Adipokines and the risk of fracture in older adults. J Bone Miner Res 2011;26:1568-1576.
7. Gasparrini M, Rivas D, Elbaz A et al. Differential expression of cytokines in subcutaneous and marrow fat of aging C57BL/6J mice. Exp Gerontol 2009;44:613-618.
8. Duque G, Huang DC, Macoritto M et al. Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis. Stem Cells 2009;27:550-558.
9. Duque G, Huang DC, Dion N et al. Interferon g plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice. J Bone Miner Res 2011 26:1472-1483.
10. Ross FP. Osteoclast biology and bone resorption. In: Rosen CJ, Compston JE, Lian JB, eds. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 7th ed. Washington: American Society for Bone and Mineral Research, 2008:16-22.
11. Ferrari Lacraz S, Ferrari S. Is IFN-γ involved in bone loss or protection? Nothing is simple with cytokines. Bonekey Osteovision 2007;4:83-87.
12. Gao Y, Grassi F, Ryan MR et al. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest 2007;117:122-132. (Pubitemid 46048459)
13. Takayanagi H, Sato K, Takaoka A et al. Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev 2005; 208:181-193. (Pubitemid 41746393)
14. Pacifici R. The immune system and bone. Arch Biochem Biophys 2010;503:41-53.
15. Takayanagi H, Ogasawara K, Hida S et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-[gamma]. Nature 2000;408:600-605.
16. Key LL Jr., Rodriguiz RM, Willi SM et al. Long-term treatment of osteopetrosis with recombinant human interferon gamma. N Engl J Med 1995;332:1594-1599.
17. Kohara H, Kitaura H, Fujimura Y et al. IFN-[gamma] directly inhibits TNF-[alpha]-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions. Immunol Lett 2011;137:53-61.
18. Ayon Haro ER, Ukai T, Yokoyama M et al. Locally administered interferon-c accelerates lipopolysaccharide-induced osteoclastogenesis independent of immunohistological RANKL upregulation. J Periodontal Res 2011;46:361-373.
19. Duque G. Bone and fat connection in aging bone. Curr Opin Rheumatol 2008;20:429-434.
20. Rosen CJ, Bouxsein ML. Mechanisms of disease: Is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2006;2:35-43. (Pubitemid 43153647)
21. Moerman EJ, Teng K, Lipschitz DA et al. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: The role of PPAR-γ2 transcription factor and TGF-β/BMP signaling pathways. Aging Cell 2004;3:379-389. (Pubitemid 40246708)
22. Duque G, Rivas D. Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells. J Bone Miner Res 2007;22:1603-1611. (Pubitemid 351229330)
23. Duque G, Macoritto M, Kremer R. 1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2). Exp Gerontol 2004;39:333-338. (Pubitemid 38264363)
24. Rickard DJ, Wang FL, Rodriguez-Rojas AM et al. Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells. Bone 2006;39:1361-1372. (Pubitemid 44827918)
25. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147. (Pubitemid 29282067)
26. Reger RL, Tucker AH, Wolfe MR. Differentiation and characterization of human MSCs. Methods Mol Biol 2008;449:93-107.
27. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (RESTV©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30:e36.
28. Rivas D, Akter R, Duque G. Inhibition of protein farnesylation arrests adipogenesis and affects PPARgamma expression and activation in differentiating mesenchymal stem cells. PPAR Res 2007;2007:81654.
29. Verma S, Rajaratnam JH, Denton J et al. Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol 2002;55:693-698. (Pubitemid 34970093)
30. Akdis M, Burgler S, Crameri R et al. Interleukins, from 1 to 37, and interferon-[gamma]: Receptors, functions, and roles in diseases. J Allergy Clin Immunol 2011;127:701-721.e1-e70.
31. Kotake S, Nanke Y, Mogi M et al. IFN-gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL. Eur J Immunol 2005;35:3353-3363. (Pubitemid 41672539)
32. Li B, Shin J, Lee K. Interferon-stimulated gene ISG12b1 inhibits adipogenic differentiation and mitochondrial biogenesis in 3T3-L1 cells. Endocrinology 2009;150:1217-1224.
33. Todoric J, Strobl B, Jais A et al. Cross-talk between interferon-γ and hedgehog signaling regulates adipogenesis. Diabetes 2011;60:1668-1676.
34. Elbaz A, Rivas D, Duque G. Effect of estrogens on bone marrow adipogenesis and Sirt1 in aging C57BL/6J mice. Biogerontology 2009; 10:747-755.
35. Lecka-Czernik B. PPARs in bone: The role in bone cell differentiation and regulation of energy metabolism. Curr Osteoporos Rep 2010;8:84-90.
36. Raefsky EL, Platanias LC, Zoumbos NC et al. Studies of interferon as a regulator of hematopoietic cell proliferation. J Immunol 1985;135: 2507-2512. (Pubitemid 16215841)
37. Naveiras O, Nardi V, Wezel PL et al. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 2009;460:259-263.
38. Sugimura R, Li L. Shifting in balance between osteogenesis and adipogenesis substantially influences hematopoiesis. J Mol Cell Biol 2010;2:61-62.